Towards a new combination therapy for tuberculosis with next generation benzothiazinones-Reference-Cited by-同舟云学术

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Published:2014-02-05 Issue:3 Volume:6 Page:372-383
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Makarov Vadim¹²,Lechartier Benoit¹³,Zhang Ming¹³,Neres João¹³,Sar Astrid M⁴,Raadsen Susanne A⁴,Hartkoorn Ruben C¹³,Ryabova Olga B¹²,Vocat Anthony¹³,Decosterd Laurent A⁵,Widmer Nicolas⁵,Buclin Thierry⁵,Bitter Wilbert⁴⁶,Andries Koen⁷,Pojer Florence¹³,Dyson Paul J⁸,Cole Stewart T¹³

Affiliation:

1. More Medicines for Tuberculosis (MM4TB) Consortium www.mm4tb.org

2. Bakh Institute of Biochemistry Russian Academy of Science Moscow Russia

3. Global Health Institute Ecole Polytechnique Fédérale de Lausanne Lausanne Switzerland

4. Department Medical Microbiology and Infection Control VU University Medical Center Amsterdam The Netherlands

5. Division of Clinical Pharmacology CHUV Hôpital Beaumont Lausanne Switzerland

6. Department of Molecular Microbiology VU University Amsterdam The Netherlands

7. Janssen Infectious Diseases Beerse Belgium

8. Institute of Chemical Sciences and Engineering École Polytechnique Fédérale de Lausanne Lausanne Switzerland

Publisher

EMBO

Subject